Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : ALLK source : Www.globenewswire.com save search
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-14 (Crawled : 20:00) - globenewswire.com
ALLK | $1.035 -2.36% 190K
|
Health Technology
|
| O: -1.15%
H: 2.33%
C: 1.55%
business year update financial results
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
Published: 2024-02-26 (Crawled : 12:00) - globenewswire.com
ALLK | $1.035 -2.36% 190K
|
Health Technology
|
| O: 2.21%
H: 10.07%
C: 5.04%
ak006 cell preclinical
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition
Published: 2024-02-12 (Crawled : 12:00) - globenewswire.com
ALLK | $1.035 -2.36% 190K
|
Health Technology
|
| O: 1.49%
H: 10.29%
C: 2.21%
ak006 publication cell
Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints
Published: 2024-01-16 (Crawled : 12:00) - globenewswire.com
ALLK | $1.035 -2.36% 190K
|
Health Technology
|
| O: -59.2%
H: 10.66%
C: -2.46%
urticaria dermatitis trials
Allakos Announces a Restructuring to Focus on Development of AK006
Published: 2024-01-16 (Crawled : 12:00) - globenewswire.com
ALLK | $1.035 -2.36% 190K
|
Health Technology
|
| O: -59.2%
H: 10.66%
C: -2.46%
ak006
Allakos Appoints Neil Graham to its Board of Directors
Published: 2023-08-30 (Crawled : 20:00) - globenewswire.com
REGN | $894.71 0.08% 180K
|
Health Technology
|
| O: 0.11%
H: 0.0%
C: -1.12%
ASLN | $0.54 20K
|
Health Technology
|
| O: 1.9%
H: 0.93%
C: -0.7%
ALLK | $1.035 -2.36% 190K
|
Health Technology
|
| O: 1.02%
H: 5.17%
C: -2.7%
Allakos Appoints Rand Sutherland and Dolca Thomas to its Board of Directors
Published: 2023-08-02 (Crawled : 20:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.6%
H: 0.11%
C: 0.11%
TBIO | News | $0.331 23K
|
Health Technology
|
| O: -0.69%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -3.79%
H: 0.0%
C: 0.0%
KRYS | $158.87 -3.11% 140K
|
Health Technology
|
| O: -2.31%
H: 0.73%
C: -1.14%
EQ | $1.715 -0.87% 62K
|
Health Technology
|
| O: 9.59%
H: 7.68%
C: -6.75%
KDNY | $40.39 0.22% -0.17% 0
|
Health Technology
|
| O: 0.02%
H: 0.26%
C: 0.22%
ALLK | $1.035 -2.36% 190K
|
Health Technology
|
| O: -0.91%
H: 1.84%
C: -1.1%
Allakos Presents Preclinical Data at EAACI Hybrid Congress 2023 Highlighting Lirentelimab and AK006 Mechanisms of Mast Cell Inhibition
Published: 2023-06-12 (Crawled : 11:00) - globenewswire.com
ALLK | $1.035 -2.36% 190K
|
Health Technology
|
| O: 0.0%
H: 5.21%
C: 2.71%
ak006 cell preclinical
Allakos Announces Upcoming Presentation on Lirentelimab and AK006 Mast Cell Inhibition at the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2023
Published: 2023-06-05 (Crawled : 11:00) - globenewswire.com
ALLK | $1.035 -2.36% 190K
|
Health Technology
|
| O: 0.0%
H: 0.95%
C: -2.29%
ak006 presentation cell immunology
Allakos Provides Business Update and Reports First Quarter 2023 Financial Results
Published: 2023-05-09 (Crawled : 20:00) - globenewswire.com
ALLK | $1.035 -2.36% 190K
|
Health Technology
|
| O: 0.46%
H: 5.54%
C: -0.92%
business update financial results
Allakos Announces Publication of AK006 Mechanism of Action Manuscript in Communications Biology
Published: 2022-11-29 (Crawled : 12:20) - globenewswire.com
ALLK | $1.035 -2.36% 190K
|
Health Technology
|
| O: 0.54%
H: 9.19%
C: 7.3%
ak006 communications publication
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-01 (Crawled : 23:00) - globenewswire.com
ALLK | $1.035 -2.36% 190K
|
Health Technology
|
| O: -2.02%
H: 7.5%
C: 4.5%
financial results report results
Allakos Announces Topline Phase 3 Data from the ENIGMA 2 Study and Phase 2/3 Data from the KRYPTOS Study in Patients with Eosinophilic Gastrointestinal Diseases
Published: 2021-12-22 (Crawled : 01:00) - globenewswire.com
ALLK | $1.035 -2.36% 190K
|
Health Technology
|
| O: -87.46%
H: 2.55%
C: -19.19%
phase 2 phase 2/3 gastrointestinal disease test topline phase 3
Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the American College of Gastroenterology 2021 Annual Scientific Meeting
Published: 2021-10-24 (Crawled : 20:20) - globenewswire.com
ALLK | $1.035 -2.36% 190K
|
Health Technology
|
| O: 3.43%
H: 2.45%
C: 0.79%
presentation disease
New Allakos Data Presented at DDW 2021 Suggest that Eosinophilic Gastritis and/or Eosinophilic Duodenitis (EG/EoD) is Highly Underdiagnosed and may be a Common Cause of Moderate-to-Severe Gastrointestinal Symptoms
Published: 2021-05-24 (Crawled : 12:00) - globenewswire.com
ALLK | $1.035 -2.36% 190K
|
Health Technology
|
| O: 0.68%
H: 0.45%
C: -2.14%
test gastrointestinal
Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the 2021 DDW Annual Meeting
Published: 2021-03-30 (Crawled : 17:00) - globenewswire.com
ALLK | $1.035 -2.36% 190K
|
Health Technology
|
| O: 0.32%
H: 1.55%
C: -0.61%
presentation disease
Allakos Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Published: 2021-03-01 (Crawled : 13:03) - globenewswire.com
ALLK | $1.035 -2.36% 190K
|
Health Technology
|
| O: 0.07%
H: 4.76%
C: -2.46%
financial results results
Allakos Appoints Natalie Holles to its Board of Directors
Published: 2020-12-22 (Crawled : 22:00) - globenewswire.com
ALLK | $1.035 -2.36% 190K
|
Health Technology
|
| O: 0.67%
H: 3.59%
C: 3.08%
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.